You are here

AusPAR: Romosozumab

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

13 February 2020
AusPAR Details
AusPAR
Active Ingredient
Romosozumab
Product Name
Evenity
Sponsor
Amgen Australia Pty. Ltd.
Submission Number
PM-2017-04339-1-5
Submission Type
New chemical entity
Decision
Approved
AusPAR Date
20 January 2020
Publication Date

13 February 2020